These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1052676)

  • 21. Structure-function relationships of somatostatin analogs.
    Marbach P; Bauer W; Briner U; Döpfner W; Petcher T; Pless J
    Horm Res; 1988; 29(2-3):54-8. PubMed ID: 2900196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of growth hormone and prolactin release by a potent enkephalin analog.
    Lien EL; Clark DE; McGregor WH
    FEBS Lett; 1978 Apr; 88(2):208-10. PubMed ID: 648632
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of gastric acid secretion by stereoisomers of somatostatin.
    Reed JD; Hirst BH; Gomez-Pan A; Coy DH; Schally AV; Meyers C
    Metabolism; 1978 Sep; 27(9 Suppl 1):1411-3. PubMed ID: 683010
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel somatostatin analogs with tyrosine kinase inhibitory and antitumor activity.
    Kéri G; Mezö I; Horváth A; Vadász Z; Balogh A; Idei M; Vántus T; Teplán I; Mák M; Horváth J
    Biochem Biophys Res Commun; 1993 Mar; 191(2):681-7. PubMed ID: 8096383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25.
    Brazeau P; Ling N; Esch F; Böhlen P; Benoit R; Guillemin R
    Regul Pept; 1981 Jan; 1(4):255-64. PubMed ID: 6114516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly.
    Charro AL; Cabranes JA; Lafuente A; Diaz-Salgado C; Cordero M; Almoguera I; Comaru-Schally AM; Meyers CA; Coy DH; Schally AV
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):432-44. PubMed ID: 6150529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.
    Murphy WA; Taylor JE; Moreau JP; Coy DH
    Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability of the duration of inhibition of growth hormone release by Nalpha-acylated-des-(Ala1-Gly2)-H2somatostatin analogs.
    Brown M; Rivier J; Vale W; Guillemin R
    Biochem Biophys Res Commun; 1975 Jul; 65(2):752-6. PubMed ID: 807218
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and biological activity of a cyclic pseudohexapeptide analog of somatostatin.
    Gero TW; Spatola AF; Torres-Aleman I; Schally AV
    Biochem Biophys Res Commun; 1984 May; 120(3):840-5. PubMed ID: 6145411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Natural peptides and their analogs. XXXV. Synthesis and properties of [Ala5, Orn9]somatostatin].
    Shvachkin IuP; Smirnova AP; Ermak NM; Fedotov VP; Sadovnikova NV
    Bioorg Khim; 1985 Aug; 11(8):1026-36. PubMed ID: 2865960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational modifications of cyclic hexapeptide somatostatin analogs.
    Freidinger RM; Perlow DS; Randall WC; Saperstein R; Arison BH; Veber DF
    Int J Pept Protein Res; 1984 Feb; 23(2):142-50. PubMed ID: 6142021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin analogs: correlation between receptor binding affinity and biological potency in GH pituitary cells.
    Schonbrunn A; Rorstad OP; Westendorf JM; Martin JB
    Endocrinology; 1983 Nov; 113(5):1559-67. PubMed ID: 6138246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acylated des-(Ala1-Gly2)-somatostatin analogs: prolonged inhibition of growth hormone secretion.
    Brazeau P; Vale W; Rivier J; Guillemin R
    Biochem Biophys Res Commun; 1974 Oct; 60(4):1202-7. PubMed ID: 4607622
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoreactive and bioactive somatostatin-like material is present in tobacco (Nicotiana tabacum).
    Werner H; Fridkin M; Aviv D; Koch Y
    Peptides; 1985; 6(5):797-802. PubMed ID: 2867523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoreactive and biologically active somatostatin-like material in rat retina.
    Rorstad OP; Brownstein MJ; Martin JB
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):3019-23. PubMed ID: 288084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies.
    Hocart SJ; Reddy V; Murphy WA; Coy DH
    J Med Chem; 1995 May; 38(11):1974-89. PubMed ID: 7783129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bicyclo-somatostatin analog, highly specific for the inhibition of growth hormone release.
    Sarantakis D; Teichman J; Clark DE; Lien EL
    Biochem Biophys Res Commun; 1977 Mar; 75(1):143-8. PubMed ID: 849303
    [No Abstract]   [Full Text] [Related]  

  • 38. Somatostatin analogs with improved oral bioavailability.
    Nutt RF; Colton CD; Veber DF; Slater EL; Saperstein R
    Klin Wochenschr; 1986; 64 Suppl 7():71-3. PubMed ID: 2882053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone release in the rat: effects of somatostatin and thyrotropin-releasing factor.
    Brown M; Vale W
    Endocrinology; 1975 Nov; 97(5):1151-6. PubMed ID: 810343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity.
    Rivier J; Brazeau P; Vale W; Guillemin R
    J Med Chem; 1975 Feb; 18(2):123-6. PubMed ID: 1091734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.